The Canadian Partnership for Tomorrow’s Health, hosted by the U of T’s Dalla Lana School of Public Health, has received a $1.9 million to identify individuals who have COVID-19 antibodies (photo by Naveen Sharma/SOPA Images/LightRocket via Getty Images)

Researchers at U of T to study presence of COVID-19 antibodies in high-?risk populations

Posted on

The Canadian Partnership for Tomorrow’s Health (CanPath), hosted by the University of Toronto’s Dalla Lana School of Public Health, has received a $1.9 million investment from Canada’s COVID-19 Immunity Task Force to fund a study of COVID-19 seroprevalence across Canada.

The study aims to identify individuals who have antibodies for COVID-19 infection but may not have been tested or experienced symptoms. It focuses on specific communities and individuals that are at higher risk of infection….

https://www.utoronto.ca/news/researchers-u-t-study-presence-covid-19-antibodies-high-risk-populations

Read More Impact Stories

Posted on
McGill-developed device offers 100 per cent accuracy in as little as 10 minutes, and can be configured to detect a [...]
Posted on
This content is available in French only.
Posted on
The University of Toronto and Moderna, Inc. known for its mRNA-based COVID-19 vaccine plan to work together to develop new [...]